Search the GHTC website
March 28, 2024

March (budget) madness: Stagnant spending package and muted budget request point to uphill battle ahead

Months of tense congressional negotiations stretching nearly six months over schedule finally concluded with the signing of a FY24 spending package in the same month President Joe Biden released his budget proposal for FY25. GHTC breaks down what this all means for global health R&D.

March 25, 2024

Research Roundup: Cholera vaccine technology transfer, TB vaccine Phase 3 trial, Promising HIV drug candidates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

March 18, 2024

Research Roundup: Promising Ebola drug, Unique nasal COVID vaccines trial, New research into sandfly that spreads leishmaniasis

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

March 15, 2024

Policy Cures Research and GHTC's new report on the returns from US investment in global health R&D featured in news articles

The newly published report from GHTC and Policy Cures Research, Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World, which looks at the returns from US investment in global health R&D, was featured in articles from Research Professional News, CIDRAP, and Infosalus.